Pyrimidine derivative compound

Details Pyrimidine derivative compound Pyrimidine derivative compound

2011-06-07

2011-06-07

Fetterolf, Brandon J (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S275000, C514S403000, C544S245000, C544S324000, C548S143000

Reexamination Certificate

active

07956060

ABSTRACT:
The present invention provides an antitumor agent and the like, which comprises as an active ingredient, a pyrimidine derivative represented by Formula (I):[wherein —X—Y—Z— represents —O—CR3═N— (wherein R3represents a hydrogen atom, a substituted or unsubstituted aromatic heterocyclic group and the like) and the like, R1represents —NR10R11(wherein R10and R11may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like) and the like, R2represents —NR13R14(wherein R13and R14may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like)] or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 6593326 (2003-07-01), Bradbury et al.
patent: 2003/0137263 (2003-07-01), Peterson
patent: 61-91184 (1986-05-01), None
patent: 2002-533446 (2002-10-01), None
patent: WO 03/009101 (2003-01-01), None
patent: WO 03/063794 (2003-08-01), None

Affiliated with

Also associated with

Rating

Pyrimidine derivative compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine derivative compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivative compound will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2732976